Almac Group, the global contract pharmaceutical development and manufacturing organisation, has announced its financial results for year ending 30 September 2023.
Kühne Holding AG has entered into a definitive agreement to acquire pharma contract development and manufacturing organisation Aenova Group from leading international investment firm BC Partners.
In an interview with Jai McIntosh, Editor for EPM, Eric Kaneps, VP, Sales and Marketing at Renaissance Lakewood explores how innovation has been at the heart of the success of the company and the market.
Bespak have announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Group to form a new standalone company.
Jimin Kim, Senior CDO Business Strategist at Samsung Biologics, lays out the challenges of successfully progressing complex biologics from clinic to commercialisation.
As we close off this year at EPM, we look back at one of our standout interviews with Alison Dillon, Director of Marketing Communications and Strategy at Sharp.
Egis Pharmaceuticals is expanding its usual activities with new elements thanks to investments exceeding a total value of more than 100 billion HUF in Hungary over the past period.
Sirio Pharma Co has announced the addition of new gummy manufacturing capabilities at its Best Formulations site, the company's manufacturing facility in the United States.
Navin Fluorine International Ltd, part of the Padmanabh Mafatlal Group, has unveiled the new identity for its contract development and manufacturing division, Navin Molecular.
Cristina Grigore, Technical Proposals Manager, Lonza Ltd discusses the evolving landscape for the role CDMOs play as essential partners with biotech for developing new medicines.
Natalia Elizalde PhD, Chief Business Development Officer, VIVEbiotech explores how the lentiviral vector specialists are bridging the gap between R&D and commercialisation.
